2019
DOI: 10.1016/j.jmb.2019.10.026
|View full text |Cite
|
Sign up to set email alerts
|

A Potent Anti-SpuE Antibody Allosterically Inhibits Type III Secretion System and Attenuates Virulence of Pseudomonas Aeruginosa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 69 publications
0
9
0
Order By: Relevance
“…The more common sequence variants in particular clustered in the domain that determines the binding specificity for biogenic amines. Considering the fact that the SpuE-mediated uptake of spermidine from the mammalian host leads to transcriptional upregulation of the type III secretion system [45, 46], the major virulence determinant of P. aeruginosa , it is reasonable to assume that within the scenario of host–pathogen interactions the sequence diversity of SpuE is translated into a batch of functional variants of differential pathogenicity.…”
Section: Resultsmentioning
confidence: 99%
“…The more common sequence variants in particular clustered in the domain that determines the binding specificity for biogenic amines. Considering the fact that the SpuE-mediated uptake of spermidine from the mammalian host leads to transcriptional upregulation of the type III secretion system [45, 46], the major virulence determinant of P. aeruginosa , it is reasonable to assume that within the scenario of host–pathogen interactions the sequence diversity of SpuE is translated into a batch of functional variants of differential pathogenicity.…”
Section: Resultsmentioning
confidence: 99%
“…Multidrug-resistant gram-negative bacteria have a significant impact on public health, and SPD uptake has been linked to the expression of type III secretion (T3SS) system genes ( 23 ), which are an essential part in their pathogenesis ( 24 , 25 ). Therefore, a SpuE antibody was designed to prevent SPD transport and ultimately weakening Pseudomonas aeruginosa infection ( 26 ). Bacterial pathogens have proven their adaptability numerous times, and by having promiscuous PBPs like PotF (or its homologs) at their disposal, they might just be able to hijack another system to facilitate SPD uptake and bypass treatment methods in the long run.…”
Section: Discussionmentioning
confidence: 99%
“…SpuE is a transcriptional regulator of the T3SS in P. aeruginosa and regulates the expression of ExsA, a master regulator of the T3SS [2], via inhibition of the exsCEBA promoter. Zhang et al derived an anti-SpuE nanobody fused with a membrane-penetrating peptide (scFv5-MPP) to assist in delivering the nanobody into the bacterial cell [145]. scFv5-MPP allosterically inhibits the expression of the T3SS and attenuates virulence of P. aeruginosa in a C. elegans animal gut infection model.…”
Section: Antibodies Targeting Intracellular Effectors and Transcriptimentioning
confidence: 99%
“…X-ray crystallography and molecular dynamics simulations were used to observe conformational changes upon antibody binding to SpuE. This conformational change may cause a reduction in spermidine uptake by P. aeruginosa leading to attenuation of virulence similar to physical neutralization [145]. A similar antibody, Mab 4E4, protects A549 cells against P. aeruginosa infection by reducing T3SS expression and polyamine uptake.…”
Section: Antibodies Targeting Intracellular Effectors and Transcriptimentioning
confidence: 99%